Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2018-03-05

Clinical Trial Update: A Study of Ibuprofen (IBU) 250mg/APAP 500mg In The Treatment Of Post-Surgical Dental Pain [Phase 3]

View source ↗

Summary

Pfizer conducted a Phase 3 trial evaluating a fixed-dose combination of ibuprofen 250 mg and acetaminophen 500 mg for post-surgical dental pain, with results po…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Acetaminophen (Acetaminophen)
  • Ibuprofen (IBUPROFEN)

Snippet

Sponsor: Pfizer | Conditions: Pain | Phase 3 | Status: COMPLETED | Results posted: 2018-03-05